MED PAPER (Morocco) Performance
| MED-PAPER | 22.10 0.91 3.95% |
MED PAPER has a performance score of 2 on a scale of 0 to 100. The company secures a Beta (Market Risk) of -0.056, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning MED PAPER are expected to decrease at a much lower rate. During the bear market, MED PAPER is likely to outperform the market. MED PAPER at this time secures a risk of 2.51%. Please verify MED PAPER total risk alpha, value at risk, and the relationship between the standard deviation and treynor ratio , to decide if MED PAPER will be following its current price movements.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in MED PAPER are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, MED PAPER is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
MED |
MED PAPER Relative Risk vs. Return Landscape
If you would invest 2,154 in MED PAPER on December 21, 2024 and sell it today you would earn a total of 56.00 from holding MED PAPER or generate 2.6% return on investment over 90 days. MED PAPER is generating 0.0712% of daily returns and assumes 2.5098% volatility on return distribution over the 90 days horizon. Simply put, 22% of stocks are less volatile than MED, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
MED PAPER Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MED PAPER's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MED PAPER, and traders can use it to determine the average amount a MED PAPER's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0284
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | MED-PAPER | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.51 actual daily | 22 78% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average MED PAPER is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MED PAPER by adding it to a well-diversified portfolio.
Things to note about MED PAPER performance evaluation
Checking the ongoing alerts about MED PAPER for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MED PAPER help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating MED PAPER's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate MED PAPER's stock performance include:- Analyzing MED PAPER's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MED PAPER's stock is overvalued or undervalued compared to its peers.
- Examining MED PAPER's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MED PAPER's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MED PAPER's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MED PAPER's stock. These opinions can provide insight into MED PAPER's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for MED Stock Analysis
When running MED PAPER's price analysis, check to measure MED PAPER's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MED PAPER is operating at the current time. Most of MED PAPER's value examination focuses on studying past and present price action to predict the probability of MED PAPER's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MED PAPER's price. Additionally, you may evaluate how the addition of MED PAPER to your portfolios can decrease your overall portfolio volatility.